Adolphe Rothschild Ophtalmologic Foundation
Also known as: Fondation A. de Rothschild | Fondation Ophtalmologique A. de Rothschild | Fondation Ophtalmologique Adolphe de Rothschild | Fondation Ophtalmologique Adolphe de Rotschild, Service de Neurochirurgie, CEntre d'Evaluation et de Traitement de la Douleur | Fondation Ophtalmologique de Rothschild | Fondation Rothschild Paris | Head of Department Ophthalmological Foundation A. de Rothschild, Paris, France | Hopital Fondation A de Rothschild | Hôpital Fondation A de Rothschild | Hôpital Fondation A. de Rothschild | Paris (FR), Adolphe Rothschild Ophtalmologic Foundation
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2010Last known activity
Mar 31, 2025
Timeline
2000s
- Jun 1, 2005
Adolphe Rothschild Ophtalmologic Foundation— Founded
Drugs by trial phase (29 distinct, 27 trials)
Phase 4 (9 own, 0 via acquisition)
Phase 3 (15 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
- Acute Lung Injury
- Aneurysm
- Blood Coagulation Disorders
- Brain Injuries
- Cataract
- Chronic Pain
- Hemorrhage
- Hemostatic Disorders
- Hypoxia
- Intracranial Aneurysm
- Intracranial Hemorrhages
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Neuralgia
- Olfaction Disorders
- Parkinson Disease
- Postoperative Pain
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Retinal Neoplasms
- Retinal Telangiectasis
- Retinoblastoma
- Sclerosis
- Syndrome
- Telangiectasis
Recent trials (35)
- NCT06585384Lead sponsorPhase 1Mar 31, 2025
- NCT06723717Lead sponsorPhase 2Feb 28, 2025
- NCT06264531Lead sponsorPhase 2/Phase 3Oct 31, 2024
- NCT06437431Lead sponsorPhase 2/Phase 3Sep 30, 2024
- NCT06342544Lead sponsorPhase 3Jun 30, 2024
- NCT05999604Lead sponsorPhase 3Nov 9, 2023
- NCT04785066Lead sponsorPhase 2Oct 31, 2021
- NCT05062031Lead sponsorN/AOct 19, 2021
- NCT04667078Lead sponsorPhase 3Sep 15, 2021
- NCT04793100Overall official - principal investigatorN/AMar 24, 2021
- NCT04793100Lead sponsorN/AMar 24, 2021
- NCT04681417CollaboratorPhase 2/Phase 3Jan 20, 2021
- NCT04361474Overall official - principal investigatorPhase 3May 18, 2020
- NCT04361474Lead sponsorPhase 3May 18, 2020
- NCT04355364Overall official - principal investigatorPhase 3Apr 15, 2020
Details
- Founded
- Geneva, CH Jun 1, 2005
- Last known activity
- Mar 31, 2025